Epstein-Barr virus infection after pediatric living-related liver transplantation-management and risk factors

Transplantation Proceedings

Volumn 42, Issue 10, 2010, Pages 4178-4180

  Shigeta, T ^a   Imadome, K ^b   Sakamoto, S ^a   Fukuda, A ^a   Kakiuchi, T ^a   Matsuno, N ^a   Tanaka, H ^a   Nakazawa, A ^a   Kasahara, M ^a  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ADD ON THERAPY; ADENOID; ADENOID HYPERTROPHY; ADOLESCENT; ADULT; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD GROUP ABO INCOMPATIBILITY; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS INFECTION; ERYTHEMA NODOSUM; FOLLOW UP; GRAFT RECIPIENT; HEMOPHAGOCYTIC SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFANT; INFECTION RISK; KIDNEY FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; PREOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SCHOOL CHILD; TREATMENT DURATION;

ABO BLOOD-GROUP SYSTEM; BLOOD GROUP INCOMPATIBILITY; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LIVER TRANSPLANTATION; LIVING DONORS; LYMPHOPROLIFERATIVE DISORDERS; RISK FACTORS;

EID: 78650462971     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.09.134     Document Type: Conference Paper

References (10)

1. C.V. Paya, J.J. Fung, and M.A. Nalesnik Epstein-Barr virusinduced posttransplant lymphoproliferative disorders ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting Transplantation 68 1999 1517
2. M.C. Fernandez, D. Bes, and M. De Davila Post-transplant lymphoproliferative disorder after pediatric liver transplantation: Characteristics and outcome Pediatr Transplantation 13 2009 307
3. F. Smets, and E.M. Sokal Epstein-Barr virus related lymphoproliferation in children after liver transplant: role of immunity, diagnosis, and management Pediatr Transplantation 6 2002 280
4. nd Ed. 2005 Elsevier Saunders Philadelphia: 1247
5. M. Hurwitz, D.M. Desai, and K.L. Cox Complete immunosuppressive withdrawal as a uniform approach to posttransplant lymphoproliferative disease in pediatric liver transplantation Pediatr Transplantation 8 2004 267
6. N. Kerkar, R.A. Morotti, and R.P. Madan The changing face of post-transplant lymphoproliferative disease in the era of molecular EBV monitoring Pediatr Transplantation 14 2010 504
7. S.J. Stevens, E.A. Verschuuren, and I. Pronk Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients Blood 97 2001 1165
8. T.C. Lee, B. Savoldo, and C.M. Rooney Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients Am J Transplant 5 2005 2222
9. S. Yokoyama, M. Kasahara, and A. Fukuda Evans syndrome after successful living-donor liver transplantation for neonatal giant cell hepatitis Transplantation 84 2007 798
10. S. Yokoyama, M. Kasahara, and A. Fukuda Epstein-Barr virusassociated erythema nodosum after living-donor liver transplantation: A case report Liver Transpl 15 2009 446